Wealth Manager - the site for professional investment managers

Register to get unlimited access to Citywire’s fund manager database. Registration is free and only takes a minute.

Lyxor dismisses ETF sale speculation as CEO exits

Lyxor Asset Management has appointed Lionel Paquin as chief executive after another high profile exit revived rumours its exchange traded fund (ETF) business is up for sale.  

Paquin replaces Inès de Dinechin, who leaves is leaving the Societe Generale-owned group, which controls some €75 billion (£61.7 billion) in assets under management.  

The news comes after significant upheaval at the firm, which saw chairman Alain Dubois leave for MSCI last June, while head Lyxor ETFs for the UK, Nordic region and Latin America, Claus Hein, also stepped down.

At the end of 2012 Simon Klein and Nizam Hamid, head and deputy head of the firm's European ETF business, quit.   

These departures sparked speculation Societe Generale was looking to offload Lyxor's ETF business, which runs €31.2 billion in assets. French asset manager Amundi was among those strongly linked with a bid.  

A spokesperson for Lyxor said in an interview with the Financial Times that de Dinechin's exit should not be read a precursor to a sale, adding that her departure was no indication the company 'needs to change its strategy'.

The spokesperson said: 'We fully understand that this is a legitimate question, but no matter how high the turnover, the results demonstrate the strength of our business.

'There are no problems with respect to the company’s atmosphere or business activity.'  

Paquin has held a number of senior roles at Lyxor since 2007 and has served as head of its Lyxor Managed Accounts Platform since 2011. Prior to this he held the positions of chief risk officer and head of internal control at the firm.

He has been with the Societe Generale group since June 2004.

Leave a comment!

Please sign in or register to comment. It is free to register and only takes a minute or two.
Citywire TV
Play Biotech Growth: we will ride out this storm

Biotech Growth: we will ride out this storm

Geoffrey Hsu of Biotech Growth Trust says the sell-off in biotechnology stocks represents a buying opportunity for long-term investors.

Play Sector Spotlight: Kleinwort Benson's Choukeir on UK equities

Sector Spotlight: Kleinwort Benson's Choukeir on UK equities

In our first Sector Spotlight of the year we explore UK equities on the back of the extreme market turbulence in 2016.

Play Picton: the UK property hotspots for rental income

Picton: the UK property hotspots for rental income

Picton Property Income CEO Michael Morris reveals how he is planning to ride the ‘ripple effect’ as UK economic growth spills out from the capital across the country.

Your Business: Cover Star Club

Profile: PortfolioMetrix is on a mission to kill 'Frankenstein' systems

Profile: PortfolioMetrix is on a mission to kill 'Frankenstein' systems

In a buyers’ market for off-the-peg discretionary management, self-funded start-ups begin at an inherent disadvantage

Wealth Manager on Twitter